Sci-Rec announced that Fortrea has announced plans to acquire Worldwide Clinical Trials’ Early Phase Services division for approximately $45m.
Public source
Publisher name
Public post
Another interesting move in the CRO market. Fortrea has announced plans to acquire Worldwide Clinical Trials’ Early Phase Services division for approximately $45m. The d…
Company
Sci-Rec
- Industry
- Staffing and Recruiting
- Location
- Leeds, GB
- Company size
- 2–10 employees
About Sci-Rec
Sci-Rec are a dedicated life science search and selection consultancy who thrive on the exciting intersection of science, talent, and innovation. With a deep understanding of the ever-evolving landscape across IVD, biotechnology and pharmaceuticals, we are committed to making meaningful connections that drive progress in these critical industries. We work globally and couldn't be further away from a typical transactional recruitment company; we take pride in building long lasting relationships and operate on a true partnership model with both clients and candidates. If you would like to learn more about our client or candidate services, don't hesitate to reach out to info@sci-rec.com.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Strategy & Corporate Development
3D CRO Search Group LLC
3D CRO Search Group LLC acquired Worldwide Clinical Trials’ Early Phase Services business for $45 million.
Strategy & Corporate Development
Worldwide Clinical Trials
Worldwide Clinical Trials announced a definitive agreement under which Fortrea will acquire its Early Phase Services division, including the Clinical Pharmacology Unit and Bioanalytical Laboratory operations.
Strategy & Corporate Development
Fortrea
Fortrea announced a definitive agreement to acquire the Early Phase Services division of Worldwide Clinical Trials to expand its early clinical development network with dedicated large and small molecule bioanalytical capabilities and increased bedspace capacity.
Strategy & Corporate Development
Vision Executives
Vision Executives announced that PRISM Vision Group, acquired by McKesson in April 2025, will take ownership of Blue Sea Capital's eye care management services organisation, Spectrum Vision Partners.
Strategy & Corporate Development
X4 Life Sciences